Fresenius Medical Care AG & Co. (Pref) (FME) PT Set at €88.00 by Independent Research GmbH

Fresenius Medical Care AG & Co. (Pref) (ETR:FME) received a €88.00 ($103.53) price target from analysts at Independent Research GmbH in a research report issued on Friday. The firm currently has a “neutral” rating on the stock. Independent Research GmbH’s price target would indicate a potential upside of 6.73% from the company’s current price.

FME has been the topic of several other research reports. Berenberg Bank set a €95.60 ($112.47) price objective on Fresenius Medical Care AG & Co. (Pref) and gave the company a “buy” rating in a research note on Tuesday, September 5th. J P Morgan Chase & Co set a €95.10 ($111.88) price objective on Fresenius Medical Care AG & Co. (Pref) and gave the company a “buy” rating in a research note on Thursday, September 14th. Goldman Sachs Group, Inc. (The) set a €97.00 ($114.12) price objective on Fresenius Medical Care AG & Co. (Pref) and gave the company a “buy” rating in a research note on Monday. Finally, Morgan Stanley set a €90.00 ($105.88) price objective on Fresenius Medical Care AG & Co. (Pref) and gave the company a “buy” rating in a research note on Friday, September 15th. One analyst has rated the stock with a sell rating, seven have issued a hold rating and nine have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average price target of €89.12 ($104.84).

COPYRIGHT VIOLATION WARNING: This article was first reported by Community Financial News and is the property of of Community Financial News. If you are accessing this article on another domain, it was illegally copied and reposted in violation of U.S. & international copyright & trademark law. The legal version of this article can be viewed at https://www.com-unik.info/2017/11/03/fresenius-medical-care-ag-88-00-by-independent-research-gmbh.html.

About Fresenius Medical Care AG & Co. (Pref)

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.

Analyst Recommendations for Fresenius Medical Care AG & Co. (Pref) (ETR:FME)

What are top analysts saying about Fresenius Medical Care AG & Co. (Pref)? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Fresenius Medical Care AG & Co. (Pref) and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit